Clinical Trial Details
— Status: Not yet recruiting
Administrative data
| NCT number |
NCT06310395 |
| Other study ID # |
AMI_H.MAR |
| Secondary ID |
|
| Status |
Not yet recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
June 15, 2024 |
| Est. completion date |
October 15, 2024 |
Study information
| Verified date |
March 2024 |
| Source |
Hospital del Mar |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Acute mesenteric ischemia (AMI) is a notorious disease with a high mortality, the diagnostic
and management is truly multidisciplinary, and the aim of this study is to analyse the
results of the patients admited with an AMI in Hospital de Mar.
Description:
Acute mesenteric ischemia (AMI) is a notorious disease with a high mortality from 50 to 80%.
Even though AMI is a relatively rare condition (1:1,000) the incidence rises exponentially
with increasing age, in patients older than 75 years, the incidence of AMI has been reported
higher than that of acute appendicitis. AMI patients benefit from early assessment in a
surgical unit with capabilities to definitive management. The diagnosis and management of AMI
are truly multidisciplinary, requiring high index of suspicion and awareness from emergency
department physicians, preferably computed tomography angiography with precise
interpretation.
The aim of this study is to analyse the results of the patients admitted with an AMI in
Hospital de Mar from January 2014 to December 2023.
